Eric Olinger retweeted
It is a must! Do not miss it!!. We all should adopt the nomenclature for CKDx with/without 🔬histology and or 🧬genetic testing
💥 Don't miss the last WG publication by G&K - Genes & Kidney
📌Chronic Kidney Disease of unexplained cause (CKDx): a consensus statement by the Genes & Kidney Working Group of the ERA.
Check it out 👉 bit.ly/3GcfUp0
Eric Olinger retweeted
Clinical Spectrum and Prognosis of Atypical ADPKD Caused by Monoallelic Pathogenic Variants of IFT140
bit.ly/4h1uEDV
@ericolinger1 @johnasayer @bet_ars @torra_roser @brousse_romain @AurelieHummel
@bertperso @ecorneclegall #VisualAbstract
Eric Olinger retweeted
Clinical Spectrum and Prognosis of Atypical ADPKD Caused by Monoallelic Pathogenic Variants of IFT140
bit.ly/4h1uEDV
@ericolinger1 @johnasayer @bet_ars @torra_roser @brousse_romain @AurelieHummel
@bertperso @ecorneclegall #VisualAbstract
Eric Olinger retweeted
🚨 Dear all, do not miss this new KDIGO webinar series on NephroGenetics 🧬 ! Please do not hesitate to share, including amongst our younger colleagues @ERAkidney @com_SFNDT @FiliereORKiD @CJNephro @ynptweets @SNINephrologie
Join us for "Hiding in Plain Sight: The Utility of Genetic Testing in Common Forms of CKD," the next module in KDIGO's new webinar series on implementing genetic testing for CKD.
Wednesday, December 4, at 3:00 PM EST. Register: kdigo.co/Module-2-Genetic-Te…
In this CME webinar, Professors Andrew Mallett, Emilie Cornec-Le Gall, Judy Savige, and Katalin Susztac will discuss the utility of genetic testing in common forms of CKD. The webinar will also examine the role of genetic testing in diagnosing cystic kidney disease, glomerular disease, and APOL1 kidney disease.
Learn more: kdigo.co/Genetic-Testing-for…
Eric Olinger retweeted
Thrilled to share a new preprint on the role of RNU4-2 and RNU5B-1 variants in neurodevelopmental disorders, now online in MedRxiv. 1/12 🧵medrxiv.org/content/10.1101/…
Eric Olinger retweeted
#UMOD Genotype and Determinants of Urinary #Uromodulin in #African Populations
#VisualAbstract by @krithicism
kireports.org/article/S2468-…
Eric Olinger retweeted
The UMOD genotype-blinded clinical trial reveals critical insights into the role of UMOD genetic variation in blood pressure regulation. This could lead to tailored treatments for hypertension patients. @HyperAHA@BHFCoREGlasgow@GlasgowB... @UofGRegiusAnna
ahajrnls.org/3XvkDqE
Eric Olinger retweeted
🌟 Highlights from Basics of Genetics for Nephrologists #ERA24
1️⃣ Will the genetic test substitute the kidney biopsy? That is already a reality for some conditions! @MuellerRom
2️⃣ The rising role of whole-genome sequencing in the kidney disease context! @ericolinger1
3️⃣4️⃣ Today’s and tomorrow’s benefits of genomics in the transplant clinic! @ADoreille
Post by @ALuisaDCorreia
Eric Olinger retweeted
Would you believe me if I told you that a single variant in a non-coding RNA explains ~0.5% of all undiagnosed individuals with neurodevelopmental disorders (NDD) in @GenomicsEngland ???
I didn’t initially either, but here is the story of RNU4-2 🧵1/9
Thrilled to share our latest discovery on a spliceosomal snRNA gene causing neurodevelopmental disorders: medrxiv.org/content/10.1101/… Thank you to everyone who contributed; it’s been a phenomenal effort to collaborate with clinicians and researchers for what would help many families!
Eric Olinger retweeted
Trio copy number analysis of Genomics England 100,000 Genomes Project identified rare biallelic deletions and SLC66A1 as a novel cause for autosomal recessive #retinopathy bit.ly/3vHPPJs @ericolinger1 @johnasayer #GIMO #GenomeSequencing #CNVAnalysis #Nephronophthisis
With a novel CNV analysis pipeline, we screened Genome Sequencing data of >10,000 parent-child trios for human "knock-out" loci: NPHP1 is the most commonly identified KO gene and SLC66A1 is a novel locus for autosomal recessive retinopathy!
gimopen.org/article/S2949-77…
A massive thanks to @johnasayer , Ian Wilson, @GenomicsEngland , and everyone involved. This would not have been possible without patients participating in research studies and the funding @Kidney_Research , @snsf_ch , @NCKRF
2
84
Prevalence and characteristics of genetic disease in adult kidney stone formers academic.oup.com/ndt/article…
Eric Olinger retweeted
Just out - the spectrum of genetic disease in unselected adult kidney stone formers.
Prevalence and characteristics of genetic disease in adult kidney stone formers academic.oup.com/ndt/article…
Eric Olinger retweeted
👩⚕️👨⚕️ Chers amis néphrologues, contribuez à notre enquête pour recenser les possibles cas de néphropathie oxalique liés aux produits lissants. Votre participation est essentielle! Répondez ici --> redcap.link/produitslissante… @com_SFNDT @Firn_sfndt #NEJM
nejm.org/doi/full/10.1056/NE…
Eric Olinger retweeted
Cystic kidney disease (#cykd) encompasses #ADPKD #PKD #ARPKD and others. What can we learn about them using national-scale #wgs? In this 🧵we explore our latest preprint from @RenalGenomics:
medrxiv.org/content/10.1101/…
Eric Olinger retweeted
#Uromodulin Processing in DNAJB11-kidney Disease
doi.org/10.1016/j.kint.2023.…
#KIResearchLetter #OpenAccess #ADPKD #ADTKD #kidneydisease #DNAJB11
@UZH_en @NCL_medresearch @UniversiteLiege @CHRU_Brest @MIKADOlab
Eric Olinger retweeted
📢 Join us at the e-seminar organised by G&K Working Group & @ynptweets:
*Understanding the #pathophysiology and #genetics of #ADTKD*
📅 November 21, 2023, at 5 PM (CET)
ERA Members can earn ECMEC® credits by participating live!
👉 bit.ly/3svojxe
Eric Olinger retweeted
Read #Openaccess: Allelic effects on #uromodulin aggregates drive autosomal dominant tubulointerstitial #KidneyDisease
By G. Schiano, O. Devuyst & colleagues @UZH_en @IREC_UCLouvain
👉doi.org/10.15252/emmm.202318…
































